Non-Steroidal Anti-Inflammatory Drugs and the Chemoprevention of Gastrointestinal Cancers

References

• Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81–106.
   PubMed Web of Science ®Google Scholar
• Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973–9.
   Google Scholar
• Morgan GP. Minimising the risks of NSAID pill oesophagitis. Int J Gastroenterol 1996;1:14016.
   Google Scholar
• Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J 1990;300:278–84.
   PubMed Web of Science ®Google Scholar
• Bjarnasson I, Hayllar J, MacPherson AJ, Russell AS. Side-effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993;104:1832–47.
   PubMed Web of Science ®Google Scholar
• Davies NM. Toxicity of non-steroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 1995;38:1311–21.
   PubMed Web of Science ®Google Scholar
• Frolich JC. A classification of NSAIDs according to the relative inhibition of cyclooxygenase enzymes. TIPS 1997;18:30–4.
   PubMed Web of Science ®Google Scholar
• Bennett A, Del Tacca M. Proceedings: prostaglandins and human colonic cancer. Gut 1975;16:409.
   PubMed Web of Science ®Google Scholar
• Pollard M, Luckert PH. Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumors. Cancer Treat Rep 1980;64:1323–7.
   PubMedGoogle Scholar
• Reddy BS, Tokumo K, Kulkarni N, Aligia C, Kellof GJ. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis 1992;13: 1019–23.
   Google Scholar
• Kune GA, Kune S, Watson LF. Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res 1988; 48:4399–404.
   Google Scholar
• Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S. A hypothesis: non-steroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355–8.
   PubMed Web of Science ®Google Scholar
• Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the reduced risk of colorectal cancer in women. N Engl J Med 1995;333:609–14.
   PubMed Web of Science ®Google Scholar
• IARC handbooks of cancer prevention, Vol 1. Non-steroidal anti-inflammatory drugs. Lyons: International Agency for Research on Cancer. In press.
   Google Scholar
• Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983;157:175–8.
   Google Scholar
• Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Gastroenterology 1991;101:635–9.
   PubMed Web of Science ®Google Scholar
• Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM. Effects of long term sulindac therapy on colonic polyposis. Ann Intern Med 1991;115:952–4.
   PubMed Web of Science ®Google Scholar
• Giardiello FM, Hamilton SR, Krush AJ, Piantdosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328:1313–6.
   PubMed Web of Science ®Google Scholar
• Niv Y, Fraser GM. Adenocarcinoma in the rectal segment in familial adenomatous polyposis is not prevented by sulindac therapy. Gastroenterology 1994;107:854–7.
   PubMed Web of Science ®Google Scholar
• Lynch HT, Thorson AG, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention: a case report. Cancer 1995;75:936–8.
   Google Scholar
• Beazer-Barclay Y, Levy DB, Moser AR, Dove WF, Hamilton SR, Vogelstein B, et al. Short communication: sulindac suppresses tumourigenesis in the Min mouse. Carcinogenesis 1996;17:1757–60.
   Google Scholar
• Oshima M, Dichuk JE, Kargman S, Oshima H, Hancock B, Kwong E, et al. Suppression of intestinal polyps in APC D761 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87:803–9.
   PubMed Web of Science ®Google Scholar
• Prescott SM, White RL. Self promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 1996;87: 783–6.
   PubMed Web of Science ®Google Scholar
• Arai M, Shimuzi S, Imai Y, Nakatsuru Y, Oda H, Oohara T, et al. Mutations of the Ki-ras, p53 and APC genes in adenocarcinomas of the human small intestine. Int J Cancer 1997;70:390–5.
   PubMed Web of Science ®Google Scholar
• DuBois RN, Radhika A, Reddy BS, Entingh AJ. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology 1996;110:1259–62.
   PubMed Web of Science ®Google Scholar
• Kargman SL, O’Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression by prostaglandin G/H synthase-1 and -2 protein in human cancer. Cancer Res 1995;55:2556–9.
   PubMed Web of Science ®Google Scholar
• Reddy BS, Rao CV, Seibert K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 1996;56: 4566–9.
   Google Scholar
• Takahasi M, Fuktake M, Yokota S, Ishida K, Wakabayashi K, Sugimura T. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclo-oxygenase 2. J Cancer Res Clin Oncol 1996;122:219–22.
   PubMed Web of Science ®Google Scholar
• Pretlow TP, O’Riordan MA, Pretlow TG, Stellato TA. Aberrant crypt in human mucosa: putative preneoplastic lesions. J Cell Biochem 1992;Suppl 16G:55–62.
   Google Scholar
• Schnitzler M, Dwight T, Robinson BG. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cell lines: an in vitro study. Gut 1996;38:707–13.
   Google Scholar
• DuBois RN, Shoa JY, Tsuji M, Sheng HM, Beauchamp RD. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 1996;56: 733–7.
   Google Scholar
• Elder DJE, Hague A, Hicks DJ, Paraskeva C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in-vitro transformed adenoma relative to adenoma cell lines. Cancer Res 1996;56:2273–6.
   PubMed Web of Science ®Google Scholar
• Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin independent pathway. Biochem Pharmacol 1996;52:237–45.
   Google Scholar
• Rubio CA. Antitumoral activity of indomethacin on experimental oesophageal tumours. J Natl Cancer Inst 1984;72:705–7.
   PubMed Web of Science ®Google Scholar
• Shimuzi T. Experimental study of esophageal cancer. Effect of alcohol, vitamin C, prostaglandin E2 and tegafur on the carcinogenesis by N-methyl-N-amyl nitrosamines and the development of esophageal carcinoma. J Jpn Soc Cancer Ther 1986;21: 1232–43.
   Google Scholar
• Botha JH, Robinson KM, Ramchurren N, Reddi K, Norman RJ. Human esophageal carcinoma cell lines: prostaglandin production, biological properties and behaviour in nude mice. J Natl Cancer Inst 1886;76:1053–6.
   Google Scholar
• Funkhouser EM, Sharp GA. Aspirin and the reduced risk of esophageal carcinoma. Cancer 1995;76:1116–9.
   PubMed Web of Science ®Google Scholar
• Morgan GP. Deleterious effects of prostaglandin E2 in oesophageal carcinogenesis. Med Hypoth 1997;48:177–81.
   PubMed Web of Science ®Google Scholar
• Chang-Claude JC, Wahrendorf J, Liang QS, Rei YG, Munoz N, Crespi M, et al. An epidemiological study of precursor lesions of esophageal cancer among young persons in a high-risk population in Hinxian, China. Cancer Res 1990;50:2286–74.
   Google Scholar
• Morgan GP, Williams JG. Inflammatory mediators in the oesophagus. Gut 1994;35:297–8.
   PubMed Web of Science ®Google Scholar
• Morgan GP. Deleterious effects of prostaglandin E2 in reflux oesophagitis. Med Hypoth 1996;46:42–4.
   PubMed Web of Science ®Google Scholar
• Zhuang Z, Vortmeyer AO, Mark EJ. Barrett’s esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive carcinomas. Cancer Res 1996; 56:1961–4.
   Google Scholar
• Fu S, Ramanujam KS, Meitzer SJ, Wilson KT. Expression and localization of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett’s esophagus. Gastroenterology 1997;112: A565.
   Web of Science ®Google Scholar
• Vaezi MF, Richter JE. Synergism of acid and duodenogastric reflux in complicated Barrett’s esophagus. Surgery 1995;117: 699–704.
   PubMed Web of Science ®Google Scholar
• Cauvin JM, Goldfain D, Le Rhun M. Multicentre prospective controlled study of Barrett’s oesophagus and colorectal adenomas. Lancet 1995;346:1391–4.
   Google Scholar
• Clark GW, Smyrk TC, Burdiles P, Hoeft SF, Peters JH, Kiyabu M, et al. Is Barrett’s metaplasia the source of adenocarcinomas of the cardia? Arch Surg 1994;129:609–14.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53: 1322–7.
   PubMed Web of Science ®Google Scholar
• Jalbert G, Castonguay A. Effects of NSAIDs on NNK-induced pulmonary and gastric carcinogenesis in A/J mice. Cancer Lett 1992;66:21–8.
   PubMed Web of Science ®Google Scholar
• Ristimaki A, Honkanen N, Jankala H, Sipponen P, Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 1997;57: 1276–80.
   Google Scholar
• van Lieshout EMM, Tiemessen DM, Peters WHM, Jansen JBMJ. Effects of nonsteroidal anti-inflammatory drugs on glutathione S-transferases of the rat digestive tract. Carcinogenesis 1997;18:485–90.
   PubMed Web of Science ®Google Scholar